AstraZeneca’s groundbreaking targeted therapy, Imfinzi (durvalumab), has secured a pivotal recommendation from the National Institute for Health and Care Excellence…
Read More
Wes Streeting Resigns as UK Health Secretary Citing Loss of Faith in Labour Leadership Following Local Election Debacle
The political landscape of the United Kingdom has been significantly reshaped by the dramatic resignation of Wes Streeting, the UK…
Read More
Foundayo Demonstrates Efficacy in Sustaining Weight Loss Post-Injectable Incretin Therapy, Presenting a Novel Oral Option
On May 13, 2024, at the 33rd European Congress on Obesity (ECO) held in Istanbul, Türkiye, groundbreaking Phase 3b trial…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
UAE Becomes First Nation to Approve AstraZeneca’s Baxfendy for Uncontrolled Hypertension
The United Arab Emirates has achieved a significant milestone in pharmaceutical innovation with the Emirates Drug Establishment (EDE) granting regulatory…
Read More
Novel Combination Therapy CagriSema Demonstrates Promising Results in Obesity Management with Preserved Muscle Strength
On 12 May 2026, at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye, groundbreaking findings from the Phase…
Read More
EU Strikes Landmark Deal on Critical Medicines Act to Fortify Pharmaceutical Sector and Ensure Patient Supply
The European Union (EU) has achieved a significant legislative milestone with the provisional agreement on the Critical Medicines Act (CMA),…
Read More
Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration
Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…
Read More
Dr. Marty Makary Resigns as FDA Commissioner Amidst Reports of Presidential Discontent
Dr. Marty Makary has formally resigned from his position as Commissioner of the U.S. Food and Drug Administration (FDA), a…
Read MoreYOU MAY HAVE MISSED
